Description
TOPOTECAN 2.5 MG is a potent chemotherapy medication used to treat various advanced malignancies. As a topoisomerase I inhibitor, it works by interfering with the genetic material (DNA) in cancer cells, preventing them from dividing and growing. Topotecan is a vital therapeutic option for patients with Small Cell Lung Cancer (SCLC) who have not responded well to initial chemotherapy, as well as for the treatment of advanced Cervical Cancer (in combination with cisplatin) and recurrent Ovarian Cancer. Its precision-guided mechanism targets rapidly multiplying cells, making it a cornerstone in second-line oncological care.
